Transcriptomics in Atherosclerosis

Section I – Introduction<br>1. Atherosclerotic CVD – epidemiology and current challenges in management<br>2. Atherosclerotic Plaque Phenotypes: Unraveling Complexity and Heterogeneity<br><br>Section II – The role of RNAs in atherosclerosis progression and development<br>3. Biogenesis and mechanisms of action of ncRNAs<br>4. The role of ncRNA in plaque development and progression<br>5. Signaling Pathways Regulating Gene Expression in Atherosclerosis<br>6. Epitranscriptomics and Atherosclerosis:<br><br>Section III – Transcriptomic Profiling of Atherosclerotic Lesions<br>7. Essentials of Transcriptomic Methods: Navigating Through RNA Sequencing and Beyond<br>8. Bridging the Gap in Transcriptomics: From Animal to Human Studies in Atherosclerosis<br>9. Translating Transcriptomics into Clinical Practice: Utilizing Gene Expression Patterns for Advanced Patient Phenotyping and Stratification in Atherosclerosis Optimizing Study Design for In-depth Transcriptomic Analysis of Atherosclerotic Plaques<br>10. Unveiling Sex-Specific Transcriptomic Mechanisms in Atherosclerosis<br><br>Section IV – Integrating Multi-Omics Approaches in Atherosclerosis Research<br>11. Combining Transcriptomics with Genomics, Proteomics, and Metabolomics<br>12. Insights into Gene Regulatory Networks in Vascular Pathology<br>13. Systems Biology and Network Analysis<br>14. Use of artificial intelligence and machine learning for multi-omics<br><br>Section V – RNA-Based Theranostics: Revolutionizing Treatment and Diagnosis in Atherosclerotic Cardiovascular Disease<br>15. RNA Therapeutics in Atherosclerosis:<br>16. RNA Therapeutic Delivery Systems – advances and challenges<br>17. Exploring Circulating RNAs: Emerging Biomarkers for Atherosclerosis Detection and Monitoring<br><br>Section VI – Conclusion<br>18. Future Directions and Emerging Technologies in Transcriptomic Research and Atherosclerosis